Category Archives: MDA

Introducing Ishmael Tamba Jalloh, October’s END7 Student of the Month

sl_murraytown_chc.jpgEach month, END7 honors one student who has made a significant contribution to our growing movement of student advocates dedicated to seeing the end of NTDs. We are very proud to introduce our October 2015 Student of the Month, Ishmael Tamba Jalloh, a pharmacy student at the University of Sierra Leone College of Medicine and Allied Health Sciences. Ishmael joined the END7 Campus Leaders Council to raise awareness of neglected tropical diseases (NTDs) in Sierra Leone by engaging students at his university in community engagement and outreach to local leaders.

As we reported while profiling Sierra Leone for our NTD Success Stories series last month, six NTDs are found in all 14 health districts in Sierra Leone, threatening nearly the entire population of the country. Strong leadership from Sierra Leone’s Ministry of Health and in-country partners has helped drive tremendous progress against NTDs like lymphatic filariasis (LF), also known as elephantiasis. More than 57 million NTD treatments had been delivered nationwide by the beginning of 2014, putting the country on track to begin the World Health Organization process of verifying the elimination of lymphatic filariasis (LF) in eight of 14 health districts. Unfortunately, when the West African Ebola epidemic reached Sierra Leone in May 2014, all public health program activities were suspended — including mass drug administration (MDA) for NTDs.

One year later, with the Ebola epidemic receding, MDA restarted in Sierra Leone. Just this month, from October 9-13, the Ministry of Health’s NTD Program, through the District Health Management Team, ran an MDA campaign targeting 1.4 million people with drugs for LF and soil-transmitted helminths (STH). Ishmael volunteered to assist with the MDA, putting his pharmacy education at the service of his community. He shares:

“The mass drug administration campaign ran from October 9th to the 13th. Before the start of the campaign, there was a training for all the health workers and volunteers at the Murray Town Community Health Center [pictured above]. After the training, we were divided into pairs (a health worker and a volunteer) and sent to various communities in Ward 390, Constituency 111, in the western part of Freetown, the capital of Sierra Leone.

“At the start of the drug administration, my team targeted a secondary school, the Sierra Leone Grammar School, in the Murray Town community. At the school, we administered albendazole and ivermectin as a prophylactic treatment for elephantiasis to 850 pupils and 50 teachers. For the remaining days of the MDA campaign, I worked in a slum community called Cockle. In that community, we targeted 1,500 residents for drug distribution.

sl_dosing.jpg“During the campaign, we used a measuring rod as a guide for the dosage we should give [pictured left]. If the individual’s height was at the 4th mark, we administered 4 tablets of ivermectin and a tablet of albendazole; if the individual’s height was at the 3rd mark, we administered 3 tablets of ivermectin and a tablet of albendazole, and so on with the second and first marks. This made it easy to give everyone the proper dose to keep them safe from elephantiasis.

“During the campaign, I found out that people are only aware of one out of the seven neglected tropical diseases — elephantiasis, which is called ‘Big Foot’ in our local language. Now, I am thinking that more work needs to be done about all of the NTDs in Sierra Leone.

“Also, during the campaign, I met an 18-year-old girl named Isatu who for the past two weeks has been developing signs of elephantiasis. Her family are saying her swollen legs are caused by witchcraft or black magic, but I advised them go to the hospital and have Isatu be tested for elephantiasis. I hope she receives the treatment she needs, and I am glad to have met her during the campaign.

“All in all, our campaign targeted 1.4 million people in Freetown. I hope my contribution to the campaign made a difference.”

Now, Ishamel is working to establish the first END7 chapter in Africa at the University of Sierra Leone. We are so grateful for Ishmael’s commitment to the fight against NTDs in Sierra Leone and around the world, and we are excited to see our community of student supporters like him grow. If you are ready to get your school involved in END7’s work, contact the END7’s student outreach coordinator at to learn how you can get started!

Celebrating NTD Success Stories: India’s Historic NTD Progress

A student holds an Albendazole tablet at a mass drug administration at the Ghorahuan School in Bihar, India.

A student holds an Albendazole tablet at a mass drug administration at the Ghorahuan School in Bihar, India.

During the month of October, END7 student supporters are celebrating NTD Success Stories from Haiti, India, Sierra Leone and the Philippines. Each country we are spotlighting has overcome their own challenges, ranging from earthquakes to the Ebola epidemic, to make sure communities receive NTD treatment and progress towards disease control and elimination. The examples of these four diverse countries help communicate not just the scope of the suffering caused by NTDs, but the hope we have of ending these diseases for good. Last week, we celebrated Haiti’s inspiring progress towards the elimination of lymphatic filariasis, and this week we’re looking across the globe to India, a historic leader against that and many other NTDs.

India’s diverse population has experienced rapid economic growth over the past two decades, but the country still faces significant health challenges due to its size and high burden of disease. Almost half of the 1.2 billion people at risk of lymphatic filariasis (LF) infection globally live in India. Additionally, NTDs such as soil-transmitted helminths (STH) negatively impact hundreds of millions of children in the country, causing delays in cognitive and physical development. These NTDs take a heavy toll on economic productivity and chronic infections perpetuate the cycle of poverty. However, the Indian government has one of the largest and most successful NTD programs in the world, and treatment scale-up is paving the way towards the elimination of LF and the control of STH infections on the subcontinent.

The Indian government first launched a pilot program to tackle LF in 1949. Over the next four decades, the government supported important research and demonstration studies that became the technical backbone of the World Health Organization’s Global Programme to Eliminate LF, launched in 2000. India’s experience with LF provided the evidence for the operational and technical feasibility of mass drug administration (MDA) to eliminate LF — a strategy that has since been adopted in countries around the world.

Today, India leads the world’s largest MDA program, reaching more than 400 million people with an annual dose of preventative medicine for LF. To date, India is one of only two countries who have achieved MDA coverage at a national level, and the population at risk of LF in the country has been reduced from 600 million to 460 million as a result. The country has also successfully scaled up efforts to control STH infections at the state level, particularly through school-based deworming programs, and recently launched a National Deworming Day to coordinate multiple platforms for deworming into one cohesive push to tackle STH in children under 19. This initiative will encourage coordinated efforts, budgeting, and monitoring to improve the efficacy and reach of deworming programs.

Several districts in India are in the process of undergoing Transmission Assessment Surveys, evaluations designed to register whether LF transmission has been interrupted and annual MDA can cease. Moving forward, bi-annual MDAs will continue in districts with a high burden of LF. Continued efforts aimed at interrupting transmission of diseases, disease surveillance, early diagnosis and response, as well as continued community mobilization and education to change risk behaviors will be critical to reducing the LF burden in India. Managing the disease among existing patients, particularly those disabled by LF with elephantiasis or hydrocele, is also a high priority.

India’s Ministry of Health and Family Welfare worked with the Global Network for Neglected Tropical Diseases in November 2014 to produce a mass media campaign, Hathipaon Mukt Bharat (Filaria Free India) to raise awareness of LF and encourage people to participate in MDAs. The video created for the campaign, entitled Giant Footprints!, won silver at the Cannes Festival of Creativity in 2015. Bollywood star Abhishek Bachchan is also supporting India’s effort against NTDs as the END7 campaign’s first official ambassador in India.

These ongoing social mobilization efforts will be critical to achieving national, regional and global NTD control and elimination goals by 2020. If India’s current NTD efforts can be maintained and expanded, those at risk for NTDs can live free of these diseases of poverty and their devastating effects. And as the leader of one of the oldest and largest programs to tackle NTDs, India can be a leader in assisting other endemic countries hoping to replicate their success around the world.

There’s ample reason to hope that history will repeat itself in India as the country celebrates the elimination of polio and looks towards new goals, like the elimination of LF. The country’s example shows that directing the expertise of different agencies and organizations towards a common goal can be successful even in a country with a large and diverse population. END7 supporters are eagerly following the good news from India — the second success story we’re spreading in a month that’s already offered many reasons to celebrate — and hoping to see it replicated worldwide.

Success in Vietnam: More than 700,000 School Children Treated!



Over the span of two months, Vietnam’s Ministry of Health, together with World Vision Australia, treated more than 700,000 school children for intestinal worms. Generous donations from END7 supporters helped support this massive effort to reach every primary school in the nine target provinces across the country.

Vietnam’s mass drug administration (MDA) was critical to improving the country’s health. Intestinal worms pose a significant threat to children in Vietnam; more than 8 million children are at risk. If infected, these children are more likely to suffer from malnutrition and anemia. Intestinal worm infections also lead to school absenteeism and decreased cognitive function. In order to reach their full potential, all at-risk children must be treated regularly.

To help address Vietnam’s burden of intestinal worms, END7 donations supported the delivery of abendazole tablets, and the training of teachers and healthcare workers. Now, END7 funds will be supporting the country’s efforts to monitor and evaluate the success of the MDA campaign.

Thanks to our END7 supporters for playing a meaningful role in the fight against neglected tropical diseases!


IMA Tanzania a Key Player in Massive National Vaccine and MDA Campaign


Image from IMA World Health

Image from IMA World Health

The Global Network for Neglected Tropical Diseases is happy to share news from IMA World Health. A first of its kind for Tanzania, the national co-implemented immunization and mass drug administration strengthened the country’s integrated efforts to control and eliminate neglected tropical diseases. 

On Saturday, October 18, IMA World Health participated in a special event in Dodoma, Tanzania, to launch the 2014 national co-implemented immunization and mass drug administration (MDA) campaign to protect 21 million children against measles, rubella and neglected tropical diseases (NTDs). One of the largest public health intervention efforts ever staged in Tanzania, the 2014 campaign will run from October 18-24.

The annual event was convened and attended by the Government of Tanzania, the United Nations Children’s Fund (UNICEF), the United States Agency for International Development (USAID), the World Health Organization (WHO), Gavi, the Vaccine Alliance, and numerous other partners.

For the past four years, IMA has been MDA for NTDs in Tanzania through the USAID-funded ENVISION Project, led by RTI International. With over $5 million in annual support, IMA has distributed preventive treatment to more than 14 million people across 9 regions of Tanzania, as well as trained 5,000 health workers and over 10,000 community volunteers.

Jim Cox, Country Director for IMA Tanzania, commented in a speech at the October 18 event, “As IMA celebrates its 20th anniversary in Tanzania… we are proud to be part of this first-ever joint NTD and immunization campaign, which lays the groundwork for healthy communities throughout Tanzania.”

IMA works with the Tanzania Ministry of Health and Social Welfare (MOHSW) to support implementation of the integrated five-disease NTD control program targeting onchocerciasis, schistosomiasis, trachoma, LF, and STH using MDA in the community and schools.

Photo from IMA World Health